Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    ALZHEIMER’S:  Scientists are Back to Square One; Will Bryostatin-1 be the Missing Link?

      Pharmaceutical companies have spent billions of dollars on Alzheimer’s research. The target has been the toxic protein, amyloid-beta. According to a recent article in NPR News, this theory was…

    Continue Reading ALZHEIMER’S:  Scientists are Back to Square One; Will Bryostatin-1 be the Missing Link?

    New Research With the Potential to Alleviate Symptoms of Parkinson’s, Alzheimer’s and Charcot-Marie-Tooth Disorders

      A recent article in the neuroscience section of the Medical Express reports the results of a study conducted by researchers in the Charcot-Marie-Tooth/Hereditary Neuropathy Center at internationally acclaimed Cedars-Sinai.…

    Continue Reading New Research With the Potential to Alleviate Symptoms of Parkinson’s, Alzheimer’s and Charcot-Marie-Tooth Disorders

    MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria

    An article in Globe Newswire quotes National Institute of Health statistics for malaria as being between 300 to 500 million cases worldwide resulting in 1.5 to 2.7 million deaths annually. People living…

    Continue Reading MALARIA: Between One Million and Two Million Deaths Each Year Worldwide.  This Company is on Target to Treat Severe Malaria
    New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
    ColiN00B / Pixabay

    New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

    A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…

    Continue Reading New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

    Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy

    The News Hub at Washington State University recently carried an article describing initial success by researchers towards developing a drug for a rare form of muscular dystrophy. Several thousand people…

    Continue Reading Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy

    The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

      A recent posting by the Leukemia and Lymphoma Society references the Beat AML Master Trial. The trial evaluates targeted therapies to treat acute myeloid leukemia (AML) and was launched…

    Continue Reading The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

    Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

    In about five years India’s population will exceed that of China which is currently ranked number one according to population. Contrast these numbers with the fact that only ten percent…

    Continue Reading Rare Diseases: Only 10% of India’s 1.37 Billion People Have Health Insurance

    In-Patient Hospitalization vs. At-Home Programs: Will Doctors Be Making House Calls Again?

    Ash Clinical News recently interviewed Dr. Bruce Leff of Johns Hopkins in connection with “hospital-at-home”, one of the major changes occurring in hospital care. Dr. Leff and his team at…

    Continue Reading In-Patient Hospitalization vs. At-Home Programs: Will Doctors Be Making House Calls Again?

    New Drug Under Review by the FDA to Treat the Most Lethal Form of Spinal Muscular Atrophy

      According to an article in Biospace, the FDA is currently reviewing data from the Phase III STRIVE clinical trial for possible approval of Zolgensma as gene therapy for spinal…

    Continue Reading New Drug Under Review by the FDA to Treat the Most Lethal Form of Spinal Muscular Atrophy

    New Personal Kinetigraph (PKG) Allows Parkinson’s Patients in the UK to Connect with their Specialists

      Although guidelines for Parkinson’s patients suggest that they visit a specialist every six months, according to a report in Parkinson’s News Today, the waiting period may be up to…

    Continue Reading New Personal Kinetigraph (PKG) Allows Parkinson’s Patients in the UK to Connect with their Specialists

    Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

      Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…

    Continue Reading Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

    New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants

      An article in BioSpace reports new information published online by the NEJM concerning Hirschsprung disease. The disease involves the absence of nerves in parts of the intestines prior to birth. Researchers…

    Continue Reading New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants
    The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation
    mcmurryjulie / Pixabay

    The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation

      A recent article in globenewswire.com news reported that the FDA has approved Fast Track Designation for AMT 130, an experimental gene therapy for the treatment of Huntington’s disease. The…

    Continue Reading The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation